Abstract 2640: XmAb808, a B7H3-targeted CD28 bispecific antibody, costimulates T cells enhancing the anti-tumor activity of clinically active CD3 T cell engagers.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Michael Hedvat, Veronica Zeng, Mayra Montes-Camacho, Charles G. Bakhit, Alex K. Lam, Lizett E. Scott, Jessica Reyes, Heather P. Jimenez, Rosio Padilla, Scott Taylor, Jose Serrato Bucio, Matthew A. Dragovich, Sung-Hyung Lee, Katrina Bykova, Yoon K. Kim, Suzanne Schubbert, Christine Bonzon, Seung Y. Chu, Gregory L. Moore, F. Rena Bahjat, John R. Desjarlais
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148777172
Cites:
Cited by:
Related to:
